Metabolomics signature of cardiovascular disease in patients with diabetes, a narrative review.

Dodangeh, Salimeh; Taghizadeh, Hananeh; Hosseinkhani, Shaghayegh; Khashayar, Pouria; Pasalar, Parvin; Meybodi, Hamid Reza Aghaei; Razi, Farideh; Larijani, Bagher.

Afiliação

Dodangeh S; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Taghizadeh H; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Hosseinkhani S; Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Khashayar P; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Pasalar P; Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Meybodi HRA; Evidence-based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Razi F; Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

J Diabetes Metab Disord ; 22(2): 985-994, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37975080